Clinical dissection of multicentric Castleman disease

被引：37

作者：

Shin, Dong-Yeop ^{[1
]}

Jeon, Yoon Kyung ^{[2
]}

Hong, Yong-Sang ^{[3
]}

Kim, Tae Min ^{[1
,4
]}

Lee, Se-Hoon ^{[1
,4
]}

Kim, Dong-Wan ^{[1
,4
]}

Kim, Inho ^{[1
,4
]}

Yoon, Sung-Soo ^{[1
,4
]}

Heo, Dae Seog ^{[1
,4
]}

Park, Seonyang ^{[1
,4
]}

Kim, Byoung Kook ^{[1
,4
]}

机构：

[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea

[2] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul Natl Univ Hosp, Seoul 151, South Korea

[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Med Oncol, Seoul, South Korea

[4] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea

来源：

LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 08期

关键词：

Castleman disease; age; splenomegaly; prognosis; Kaposi sarcoma-associated herpes virus; KAPOSIS-SARCOMA; DNA-SEQUENCES; IL-6; POPULATION; MANAGEMENT; LYMPHOMA; SURVIVAL;

D O I：

10.3109/10428194.2011.574759

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This study investigated the prognostic factors of Castleman disease (CD) and focused specifically on multicentric CD (MCD). Seventy patients with CD were studied. Forty-three patients (61.5%) had unicentric CD (UCD) and 27 patients (38.5%) had MCD. Thirty-six patients with UCD (83.7%) underwent surgical excision, and 25 patients with MCD (92.6%) received systemic treatment, including corticosteroids and combination chemotherapy. In the patients with MCD, age >60 years and the presence of splenomegaly were prognostic factors for progression-free survival (hazard ratio [HR] 9.01, 95% confidence interval [CI] 2.64-30.83 and HR 4.32, 95% CI 1.16-16.09) as well as overall survival (OS) in MCD (HR 8.7, 95% CI 2.83-26.84 and HR 2.9, 95% CI 0.95-9.02, respectively). Patients <= 60 years old without splenomegaly showed better OS than patients >60 years old or with splenomegaly (71.4% vs. 10.8% for 5-year OS). MCD might be dissected clinically by the simple parameters of age and presence of splenomegaly.

引用

页码：1517 / 1522

页数：6

共 30 条

[11] IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].

CHANG, Y ;

CESARMAN, E ;

PESSIN, MS ;

LEE, F ;

CULPEPPER, J ;

KNOWLES, DM ;

MOORE, PS .

SCIENCE, 1994, 266 (5192) :1865-1869

[12] Epidemiology of HIV/AIDS - Current Status, Trend and Prospect - [J].

Choe, Kang Won .

JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2007, 50 (04) :296-302

[13]

Chronowski M, 2001, CANCER, V92, P670

[14] Castleman disease [J].

Dham, Anu ;

Peterson, Bruce A. .

CURRENT OPINION IN HEMATOLOGY, 2007, 14 (04) :354-359

[15] Treatment of Castleman's disease [J].

Dispenzieri A. ;

Gertz M.A. .

Current Treatment Options in Oncology, 2005, 6 (3) :255-266

[16] Clinical and laboratory characterization of a large cohort of patients with Castleman disease retrospectively collected from a single center [J].

Dong, Yujun ;

Na, Jia ;

Lv, Jicheng ;

Wang, Rengui ;

Chen, Xixue ;

Li, Nan ;

Ren, Hanyun .

LEUKEMIA & LYMPHOMA, 2009, 50 (08) :1308-1317

[17] Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma [J].

Dupin, N ;

Fisher, C ;

Kellam, P ;

Ariad, S ;

Tulliez, M ;

Franck, N ;

van Marck, E ;

Salmon, D ;

Gorin, I ;

Escande, JP ;

Weiss, RA ;

Alitalo, K ;

Boshoff, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4546-4551

[18] Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus-associated multicentric Castleman's disease:: ANRS 117 CastlemaB trial [J].

Gerard, Laurence ;

Berezne, Alice ;

Galicier, Lionel ;

Meignin, Veronique ;

Obadia, Martine ;

De Castro, Nathalie ;

Jacomet, Christine ;

Verdon, Renaud ;

Madelaine-Chambrin, Isabelle ;

Boulanger, Emmanuelle ;

Chevret, Sylvie ;

Agbalika, Felix ;

Oksenhendler, Eric .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) :3350-3356

[19] Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells [J].

Guihot, Amelie ;

Oksenhendler, Eric ;

Galicier, Lionel ;

Marcelin, Anne-Genevieve ;

Papagno, Laura ;

Bedin, Anne-Sophie ;

Agbalika, Felix ;

Dupin, Nicolas ;

Cadranel, Jacques ;

Autran, Brigitte ;

Carcelain, Guislaine .

BLOOD, 2008, 111 (03) :1387-1395

[20] The clinical behavior of localized and multicentric Castleman disease [J].

Herrada, J ;

Cabanillas, F ;

Rice, L ;

Manning, J ;

Pugh, W .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (08) :657-662

← 1 2 3 →